Advancing treatment strategies: Insights from network meta-analysis of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

doi:10.4251/wjgo.v17.i1.99083

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (169)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

134

Sum=140

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=24

Jan 15, 2025 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastrointest Oncol. Jan 15, 2025; 17(1): 99083
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99083

Advancing treatment strategies: Insights from network meta-analysis of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

Chun-Han Cheng, Wen-Rui Hao, Tzu-Hurng Cheng

Chun-Han Cheng, Department of Medical Education, Linkou Chang Gung Memorial Hospital, Taoyuan City 33305, Taiwan

Wen-Rui Hao, Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei City 23561, Taiwan

Wen-Rui Hao, Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11002, Taiwan

Tzu-Hurng Cheng, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, Taichung City 404328, Taiwan

Co-first authors: Chun-Han Cheng and Wen-Rui Hao.

Author contributions: Cheng CH and Hao WR contribute equally to this study as co-first authors. Cheng CH and Hao WR wrote the paper; Cheng TH revised the paper; all authors have read and approved the final manuscript.

Conflict-of-interest statement: The authors declare having no conflicts of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung City 404328, Taiwan. thcheng@mail.cmu.edu.tw

Received: July 13, 2024
Revised: September 26, 2024
Accepted: October 23, 2024
Published online: January 15, 2025
Processing time: 152 Days and 2.4 Hours

Core Tip

Core Tip: This study discusses the comprehensive findings of the network meta-analysis of Zhou et al on hepatic arterial infusion chemotherapy (HAIC) and its combination strategies for advanced hepatocellular carcinoma. It highlights the efficacy and comparative benefits of HAIC in improving treatment outcomes and emphasizes its potential as a targeted therapeutic option in clinical practice.